Summary
The a2 Milk Company has announced the launch of two new ultra-premium infant formula products in China, further expanding its presence in the country's ultra-premium infant formula segment. The dual launch is aimed at deepening the brand's quality moat and reinforcing its high-end product matrix built around the differentiated positioning of A2 protein. The report, published on Sina Finance, focuses on a2's product strategy amid premiumising competition in China's infant formula market.
The original text consists mainly of web scripts and page code and does not disclose specific product names, formulation parameters, pricing, launch dates or sales targets, nor does it provide executive statements or specific third-party market metrics.
Commentary
The a2 Milk Company's launch of two new ultra-premium infant formula products in China marks a key step in deepening its A2 protein differentiation strategy. China's infant formula market has entered a phase of stock competition, with premiumisation and functionalisation becoming the main growth engines. According to Euromonitor data, the China infant formula market was worth about RMB 180 billion in 2025, with ultra-premium products continuing to increase their share and growing faster than the industry average.
Leveraging its unique A2 protein positioning, a2 has built strong brand recognition in China, with Greater China accounting for more than 40 percent of its global revenue. The dual launch is intended to further consolidate its position in the ultra-premium segment and respond to intense competition from brands such as Feihe, Yili Jinlingguan and Wyeth Illuma. For NZ SMEs, a2's move sends a clear signal: Chinese consumers' demand for functional and differentiated dairy products is still growing, but the barriers to market entry are also rising.
New Zealand dairy exports are highly dependent on the China market, with large co-operatives such as Fonterra dominating, but smaller dairy firms can draw lessons from the a2 model — building differentiation through niche category innovation (such as grass-fed, organic and A2 protein) rather than competing head-on with giants in the standard formula market. At the same time, they need to watch for the strong rise of local Chinese brands in the premium segment and the risks posed by changes in cross-border e-commerce channel policies. Specific details of a2's new product launches have not yet been disclosed, and their market performance will test whether the incremental space in ultra-premium infant formula is sufficient to support the growth expectations of multiple companies.
Keywords: a2, infant formula, ultra-premium infant formula, new product launch, China market, quality moat, A2 protein
Source: Sina
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.





